Clinical Indication

Hyperprolactinaemic disorders


Annual monitoring undertaken in secondary care Primary care should be aware of fibrotic reactions

Date of classification

May 2019


Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .